Profile data is unavailable for this security.
About the company
Chongqing Genrix Biopharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of antibody drugs. The Company’s products mainly include monoclonal antibody drugs and bispecific antibody drugs under research. In terms of source innovation, the Company has established a new phage-based presented two technical platforms, the monoclonal antibody drug discovery technology platform and the bispecific antibody drug discovery technology platform and established an efficient recombinant antibody drug process development platform in the drug development process.
- Revenue in CNY (TTM)13.56m
- Net income in CNY-779.42m
- Incorporated2015
- Employees547.00
- LocationChongqing Genrix Biopharmaceutical Co LtdCHONGQING 401338ChinaCHN
- Phone+86 2 361758666
- Fax+86 2 361758011
- Websitehttp://www.genrixbio.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Changchun BCHT Biotechnology Co | 1.61bn | 414.29m | 10.73bn | 1.24k | 25.92 | 2.56 | -- | 6.68 | 1.00 | 1.00 | 3.88 | 10.15 | 0.3181 | 1.00 | 1.06 | 1,295,333.00 | 8.20 | 9.95 | 10.23 | 12.81 | 87.55 | 86.63 | 25.77 | 24.03 | 1.85 | -- | 0.0147 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
| Guobang Pharma Ltd | 5.71bn | 702.28m | 10.86bn | 4.23k | 15.42 | 1.39 | -- | 1.90 | 1.26 | 1.26 | 10.26 | 14.03 | 0.5599 | 3.29 | 7.84 | 1,350,536.00 | 6.87 | 10.36 | 8.88 | 14.24 | 23.87 | 27.49 | 12.27 | 15.01 | 1.70 | -- | 0.1992 | 18.24 | -6.49 | 10.28 | -33.49 | 23.77 | 35.60 | -- |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.58bn | 421.47m | 10.90bn | 1.55k | 26.32 | 4.17 | -- | 6.92 | 1.88 | 1.88 | 7.14 | 11.91 | 0.4286 | 1.19 | 3.67 | 1,020,281.00 | 11.58 | 5.86 | 16.99 | 7.59 | 67.12 | 55.41 | 27.01 | 17.20 | 0.912 | 24.02 | 0.3477 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 2.58bn | 114.60m | 10.94bn | 2.55k | 97.34 | 1.41 | -- | 4.24 | 0.1194 | 0.1194 | 2.74 | 8.24 | 0.2118 | 1.48 | 0.7645 | 1,014,704.00 | 0.8822 | 3.48 | 1.17 | 4.78 | 34.52 | 38.93 | 4.17 | 10.08 | 2.23 | -- | 0.2888 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
| Chongqing Genrix Biophrmctcl Co Ltd | 13.56m | -779.42m | 11.03bn | 547.00 | -- | 4.69 | -- | 813.12 | -2.13 | -2.13 | 0.037 | 6.42 | 0.0039 | 0.1009 | 1.37 | 24,790.27 | -22.22 | -- | -23.06 | -- | 55.87 | -- | -5,747.82 | -- | 18.62 | -- | 0.2454 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 3.48bn | 482.37m | 11.04bn | 2.88k | 22.89 | 2.76 | -- | 3.17 | 1.12 | 1.12 | 8.08 | 9.28 | 0.6872 | 6.42 | 8.53 | 1,208,299.00 | 9.74 | 10.82 | 11.64 | 13.47 | 44.84 | 41.18 | 14.17 | 14.08 | 4.40 | -- | 0.0936 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Liaoning Chengda Biotechnology Co Ltd | 1.72bn | 332.10m | 11.34bn | 1.73k | 33.90 | 1.19 | -- | 6.60 | 0.8032 | 0.8032 | 4.16 | 22.93 | 0.1702 | 0.763 | 1.43 | 991,973.80 | 3.29 | 10.63 | 3.41 | 11.01 | 80.53 | 85.74 | 19.33 | 39.56 | 17.44 | -- | 0.0018 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 2.01bn | 557.43m | 11.45bn | 2.47k | 20.55 | 2.57 | -- | 5.70 | 1.27 | 1.27 | 4.58 | 10.18 | 0.3977 | 2.75 | 10.26 | 812,720.60 | 11.04 | -- | 11.82 | -- | 41.64 | -- | 27.76 | -- | 6.39 | -- | 0.0234 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| KPC Pharmaceuticals Inc | 7.55bn | 446.07m | 11.53bn | 5.05k | 25.71 | 2.08 | -- | 1.53 | 0.5924 | 0.5924 | 10.03 | 7.31 | 0.7819 | 2.75 | 2.56 | 1,494,697.00 | 4.64 | 5.42 | 7.75 | 9.13 | 40.84 | 43.68 | 5.94 | 5.70 | 1.51 | -- | 0.172 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
Data as of Sep 13 2024. Currency figures normalised to Chongqing Genrix Biopharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
49.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 10.90m | 12.24% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 7.99m | 8.97% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 4.68m | 5.25% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 4.60m | 5.16% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 3.83m | 4.30% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 3.73m | 4.19% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 2.41m | 2.70% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 2.08m | 2.34% |
| China Fund Management Co., Ltd.as of 30 Jun 2024 | 1.81m | 2.03% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 1.63m | 1.83% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
